Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,86
KB-0,23
PKN78,6278,72,85
Msft297,38297,42-0,72
Nokia4,77954,7835-0,61
IBM137,83137,850,82
Daimler AG74,2174,221,64
PFE44,1944,20,01
24.09.2021 16:54:47
Indexy online
AD Index online
select
AD Index online
 

  • 23.09.2021
Antibiotice SA (ROATB.BX, Bucharest)
Závěr k 23.9.2021 Změna (%) Změna (RON) Objem obchodů (RON)
0,56 1,82 0,01 28 124
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 24.09.2021
Popis společnosti
Obecné informace
Název společnostiAntibiotice SA
TickerATB
Kmenové akcie:Ordinary Shares
RICATB.BX
ISINROATBIACNOR9
Poslední známé roční výsledky31.12.2020
Poslední známé čtvrtletní výsledky30.06.2021
Počet zaměstnanců k 30.06.2021 1 415
Akcie v oběhu k 30.06.2021 671 338 040
MěnaRON
Kontaktní informace
Ulicestr. Valea Lupului nr.1
MěstoIASI
PSČ707410
ZeměRomania
Kontatní osobaCerasela Moraru
Funkce kontaktní osobyInvestor Relation Officer
Telefon40 232 209 583
Fax40232209633
Kontatní telefon40 232 209 583

Business Summary: Antibiotice SA is a Romania-based company primarily active in the pharmaceutical industry. The Company manufactures drugs in five pharmaceutical forms: powder for injectable solutions and suspensions, capsules, tablets, suppositories and preparations. The Company's products are designed to treat a range of diseases, including infectious, dermatology, cardiovascular, digestive and musculoskeletal system related. The Company operates eight certified production lines. Its portfolio includes products for human and veterinary use, pharmaceutical ingredients and biological fertilizers. Additionally, the Company is engaged in the research and development activities.
Financial Summary: BRIEF: For the six months ended 30 June 2021, AntibioticeSA revenues increased 10% to RON161.4M. Net incomeincreased 1% to RON19.3M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income was partiallyoffset by Staff-related expenses increase of 9% to RON54.8M(expense), Advertising Expenses increase from RON2.2M toRON4.5M (expense).
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Pharmaceutical Preparation Manufacturing
SICPharmaceutical Preparations



  • Poslední aktualizace: 24.09.2021
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President of the Management BoardLucian Timofticiuc-24.06.202124.06.2021
Executive Vice Chairman, Chief Executive OfficerIoan Nani5926.04.201201.01.1994
Economic/Financial DirectorPaula Coman5106.06.201106.06.2011
Technical and Production DirectorCornelia Moraru53
Engineering and Investments DirectorEugen Osadet64
Research and Development DirectorCristina Diaconescu51
Marketing and Domestic Sales DirectorOvidiu Bataga41
Marketing and International Market Sales DirectorDelia Racoveanu47
Commercial/Business and Logistics DirectorVasile Chebac64
Human Resources DirectorGica Rusu56